Company announcement “ No. 22 / 2024 Zealand Pharma launches long-term incentive programs for Zealand's Board of Directors, Corporate Management and employees for 2024 Copenhagen,...
Company announcement “ No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Correction to Company announcement “ No. 23 / 2024 Copenhagen, Denmark, April 19, 2024 “ Zealand Pharma A/S (Zealand) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology...
Copenhagen, Denmark, March 31, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital.
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of EW
Transactions in Zealand Pharma shares and/or related securities
Company announcement “ No. 18 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 21 March 2024 “ Zealand Pharma A/S (Zealand) (Nasdaq: ZEAL)...
Company announcement “ No. 15 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...